David Chan

3.0k total citations
85 papers, 1.2k citations indexed

About

David Chan is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, David Chan has authored 85 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 45 papers in Epidemiology and 33 papers in Neurology. Recurrent topics in David Chan's work include Neuroendocrine Tumor Research Advances (43 papers), Lung Cancer Research Studies (39 papers) and Neuroblastoma Research and Treatments (32 papers). David Chan is often cited by papers focused on Neuroendocrine Tumor Research Advances (43 papers), Lung Cancer Research Studies (39 papers) and Neuroblastoma Research and Treatments (32 papers). David Chan collaborates with scholars based in Australia, Canada and United States. David Chan's co-authors include Nick Pavlakis, Simron Singh, Eva Segelov, Stephen Clarke, Calvin Law, Dale L. Bailey, Man Ken Cheung, Timothy Price, Paul Roach and Bob T. Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David Chan

81 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Chan Australia 22 869 557 394 289 194 85 1.2k
Ana Custodio Spain 21 705 0.8× 334 0.6× 246 0.6× 306 1.1× 175 0.9× 75 1.2k
Ferdinando Riccardi Italy 18 602 0.7× 283 0.5× 108 0.3× 296 1.0× 122 0.6× 77 875
Louis de Mestier France 24 1.5k 1.7× 1.3k 2.3× 781 2.0× 251 0.9× 193 1.0× 128 2.1k
Jeroen Dekervel Belgium 18 617 0.7× 239 0.4× 118 0.3× 165 0.6× 230 1.2× 69 1.1k
Glenwood D. Goss Canada 20 541 0.6× 253 0.5× 137 0.3× 327 1.1× 396 2.0× 39 1.2k
Menghua Dai China 21 1.1k 1.2× 338 0.6× 89 0.2× 394 1.4× 227 1.2× 107 1.5k
Van Anh Trinh United States 17 968 1.1× 202 0.4× 127 0.3× 203 0.7× 41 0.2× 38 1.3k
Yasuo Ejima Japan 20 379 0.4× 210 0.4× 110 0.3× 394 1.4× 215 1.1× 49 1.3k
Eugenio Villa Italy 14 676 0.8× 114 0.2× 100 0.3× 396 1.4× 157 0.8× 20 973

Countries citing papers authored by David Chan

Since Specialization
Citations

This map shows the geographic impact of David Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chan more than expected).

Fields of papers citing papers by David Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chan. The network helps show where David Chan may publish in the future.

Co-authorship network of co-authors of David Chan

This figure shows the co-authorship network connecting the top 25 collaborators of David Chan. A scholar is included among the top collaborators of David Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chan. David Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pavlakis, Nick, Malinda Itchins, Jennifer Arena, et al.. (2023). The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer. Journal of Clinical Medicine. 12(5). 1989–1989. 24 indexed citations
2.
McGarrah, Patrick W., Alan Paciorek, Amr Mohamed, et al.. (2023). Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review. Clinical Genitourinary Cancer. 21(3). 403–414.e5. 5 indexed citations
3.
Chan, David, Aimee R. Hayes, Ioannis Karfis, et al.. (2023). [18F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study. Journal of Nuclear Medicine. 65(2). 185–191. 7 indexed citations
4.
5.
Chan, David, Stephen Clarke, Alexander Engel, et al.. (2021). Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT). European Journal of Clinical Nutrition. 76(1). 143–149. 14 indexed citations
6.
Chan, David, Jennifer Arena, Elizabeth J. Bernard, et al.. (2021). Life-threatening diarrhea in neuroendocrine tumors: two case reports. Journal of Medical Case Reports. 15(1). 542–542. 1 indexed citations
7.
Chua, Terence C., Christopher B. Nahm, Nick Pavlakis, et al.. (2021). Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy. European Journal of Surgical Oncology. 47(10). 2543–2550. 11 indexed citations
8.
Fuchs, Talia L., A. Scott Pearson, Connie I. Diakos, et al.. (2020). Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases. Pathology. 52(5). 515–521. 3 indexed citations
9.
Davis, Andrew A., Wade T. Iams, David Chan, et al.. (2020). Early Assessment of Molecular Progression and Response by Whole-genome Circulating Tumor DNA in Advanced Solid Tumors. Molecular Cancer Therapeutics. 19(7). 1486–1496. 17 indexed citations
10.
Chan, Joseph, Connie I. Diakos, Alexander Engel, et al.. (2020). Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer. PLoS ONE. 15(1). e0228466–e0228466. 4 indexed citations
11.
Davis, Andrew A., Wade T. Iams, David Chan, et al.. (2019). P1.01-49 Serial Changes in Whole-Genome Cell-Free DNA (cfDNA) to Identify Disease Progression Prior to Imaging in Advanced NSCLC. Journal of Thoracic Oncology. 14(10). S377–S377. 1 indexed citations
12.
Chan, David, Matthew C. Cheung, Craig C. Earle, et al.. (2019). Are We Choosing Surveillance Imaging in Gastric and Pancreatic Cancers Wisely? A Population-Based Study. Journal of Gastrointestinal Cancer. 51(1). 189–195. 2 indexed citations
13.
Chan, David, Elizabeth J. Bernard, Geoffrey Schembri, et al.. (2019). High Metabolic Tumour Volume on 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Poor Survival from Neuroendocrine Neoplasms. Neuroendocrinology. 110(11-12). 950–958. 24 indexed citations
14.
Chan, David, Robert J. Thompson, Mandy M. Lam, et al.. (2018). External Beam Radiotherapy in the Treatment of Gastroenteropancreatic Neuroendocrine Tumours: A Systematic Review. Clinical Oncology. 30(7). 400–408. 24 indexed citations
15.
Chan, David & Simron Singh. (2018). Developments in the treatment of carcinoid syndrome – impact of telotristat. Therapeutics and Clinical Risk Management. Volume 14. 323–329. 5 indexed citations
16.
17.
Chan, David, Matthew Dixon, Calvin Law, et al.. (2018). Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases. Annals of Surgical Oncology. 25(6). 1768–1774. 21 indexed citations
18.
Mong, Jamie, Jun Shi, David Chan, et al.. (2017). Single-cell combined mutation and gene expression studies of circulating tumor-associated cells in non-small cell lung cancer. Annals of Oncology. 28. v35–v35.
19.
Chan, David, Matthew H. Wong, Bob T. Li, et al.. (2016). Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors. Neuroendocrinology. 104(3). 209–222. 11 indexed citations
20.
Chan, David, Stephen Clarke, Anthony J. Gill, et al.. (2015). Pathogenic PALB2 mutation in metastatic pancreatic adenocarcinoma and neuroendocrine tumour: A case report. Molecular and Clinical Oncology. 3(4). 817–819. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Custodio Breakdown of academic impact, for papers by Ferdinando Riccardi Breakdown of academic impact, for papers by Louis de Mestier Breakdown of academic impact, for papers by Jeroen Dekervel Breakdown of academic impact, for papers by Glenwood D. Goss Breakdown of academic impact, for papers by Menghua Dai Breakdown of academic impact, for papers by Van Anh Trinh Breakdown of academic impact, for papers by Yasuo Ejima Breakdown of academic impact, for papers by Eugenio Villa
Rankless by CCL
2026